The National Foundation for Cancer Research (NFCR) announced today that the 2018 Szent-Györgyi Prize for Progress in Cancer Research will be awarded to Douglas R. Lowy, M.D., and John T. Schiller, Ph.D., for development of vaccines for human papillomavirus (HPV), which causes 99% of cervical cancer cases. Collaborators for over 30 years at the U.S. National Cancer Institute (NCI) in Bethesda, Lowy and Schiller developed the first Food and Drug Administration approved vaccines specifically targeting cancer.
{iframe}https://www.prnewswire.com/news-releases/duo-of-oncology-vaccine-pioneers-at-the-national-cancer-institute-to-receive-2018-annual-szent-gyorgyi-prize-for-progress-in-cancer-research-300599354.html{/iframe}